power, its a rumor they were also on DPZ I have not read any info on that do you have a link. I would greatly appreciate it...
Look even IF they were on, DPZ the first 6 months then so what.
1. DPZ is known to show only a small improvement on AD patients ONLY for the first months. The whole group is doing better especially the six, 2 years down the road.
2. The whole group is doing much better than SOC DPZ
3. If I were the CEO of Pfizer I would want then, If the tow enforce each other which I doubt, want to acquire Anavex for A2-73
The point is that A2-73 is doing way, way better than donepezil so it cant be donepezil ....
Market Data 
Markets 
AI
